$101.80
-3.04-2.9%
Last update: Nov 6, 7:33 PM
Medtronic PLC
MDTNYSE
Medtronic (MDT) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | Sep 1, 2026 | $1.45 | $1.39 | 4.32 % |
| Q4 | Jun 3, 2026 | $1.55 | $1.55 | 0.00 % |
| Q3 | Feb 17, 2026 | $1.36 | $1.33 | 2.26 % |
| Q2 | Nov 18, 2025 | $1.36 | $1.31 | 3.82 % |
Quarterly Revenue (Billions)
Medtronic (MDT) last issued guidance on September 1, 2026 for Q2 2027. The company guided earnings per share in the range of $1.32 - $1.34, compared to a consensus EPS estimate of $1.35.
Compared to prior guidance, Medtronic lowered its EPS outlook from a previous range of $5.94 - $6.
Medtronic has issued 18 guidance updates between November 22, 2022 and September 1, 2026. During this period, the company raised its outlook 5 times and lowered it 2 times, providing investors with insight into management's evolving expectations.
| Metric | Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $1.39 | $1.55 | $1.33 | $1.31 |
| Actual | $1.45 | $1.55 | $1.36 | $1.36 |
| Surprise | +4.32% | 0.00% | +2.26% | +3.82% |
| Revenue | ||||
| Estimate | $9.53B | $9.62B | $8.89B | $8.86B |
| Actual | $9.76B | $9.81B | $9.02B | $8.96B |
| Surprise | +2.37% | +1.91% | +1.39% | +1.12% |
| Metric | Q2 '27E | Q3 '27E | Q4 '27E | Q1 '28E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $1.33 | $1.43 | $1.76 | $1.47 |
| Revenue | ||||
| Consensus | $9.48B | $9.52B | — | — |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | Sep 1, 2026 | $9.76B | $9.53B | 2.37 % |
| Q4 | Jun 3, 2026 | $9.81B | $9.62B | 1.91 % |
| Q3 | Feb 17, 2026 | $9.02B | $8.89B | 1.39 % |
| Q2 | Nov 18, 2025 | $8.96B | $8.86B | 1.12 % |
